Medical Equipment

New BioSticker Medical Device is for Single-Use and Can Collect Data up to 30 Days
Medical Equipment

New BioSticker Medical Device is for Single-Use and Can Collect Data up to 30 Days

Enables remote data capture of symptomatic events and multi-parameter biometrics for complex care and symptoms directly associated with COVID-19. Offers multi-parameter remote patient monitoring and algorithmic reporting of minute-level vital signs, physiological biometrics and symptomatic events. Features remote data capture and reporting of patient's symptomatic coughing, sneezing and vomiting...

Read More »
New BioSticker Medical Device is for Single-Use and Can Collect Data up to 30 Days
Medical Equipment

New BioSticker Medical Device is for Single-Use and Can Collect Data up to 30 Days

Enables remote data capture of symptomatic events and multi-parameter biometrics for complex care and symptoms directly associated with COVID-19. Offers multi-parameter remote patient monitoring and algorithmic reporting of minute-level vital signs, physiological biometrics and symptomatic events. Features remote data capture and reporting of patient's symptomatic coughing, sneezing and vomiting...

Read More »
Reliefband® Wearable Devices for the Prevention and Treatment of Nausea Symptoms Receive FDA Approval for Expanded Uses
Wristbands

Reliefband® Wearable Devices for the Prevention and Treatment of Nausea Symptoms Receive FDA Approval for Expanded Uses

FDA Clears Indications for Nausea and Vomiting Related to Physician-Diagnosed Migraines as well as Anxiety and Hangovers LAS VEGAS (PRWEB) JANUARY 06, 2020 - Reliefband Technologies LLC, an innovator in wearable technology that prevents and treats nausea and vomiting symptoms, announced its Reliefband® family of wearable therapeutic devices have received U.S. Food and Drug Administration (FDA)...

Read More »
Reliefband-® Wearable Devices for the Prevention and Treatment of Nausea Symptoms Receive FDA Approval for Expanded Uses
Wristbands

Reliefband-® Wearable Devices for the Prevention and Treatment of Nausea Symptoms Receive FDA Approval for Expanded Uses

FDA Clears Indications for Nausea and Vomiting Related to Physician-Diagnosed Migraines as well as Anxiety and Hangovers LAS VEGAS (PRWEB) JANUARY 06, 2020 - Reliefband Technologies LLC, an innovator in wearable technology that prevents and treats nausea and vomiting symptoms, announced its Reliefband® family of wearable therapeutic devices have received U.S. Food and Drug Administration (FDA)...

Read More »
ThermoGenesis Holdings Updates 510(K) Listing with the FDA to Include Its Next Generation PXP®-1000 System for Advanced Cellular Processing
Medical Equipment

ThermoGenesis Holdings Updates 510(K) Listing with the FDA to Include Its Next Generation PXP®-1000 System for Advanced Cellular Processing

RANCHO CORDOVA, Calif., Dec. 10, 2019 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it has completed the development process and submitted a Letter to the Design History File and updated the device listing with the U.S. Food and Drug Administration (FDA) for the...

Read More »
ThermoGenesis Holdings Updates 510(K) Listing with the FDA to Include Its Next Generation PXP-®-1000 System for Advanced Cellular Processing
Medical Equipment

ThermoGenesis Holdings Updates 510(K) Listing with the FDA to Include Its Next Generation PXP-®-1000 System for Advanced Cellular Processing

RANCHO CORDOVA, Calif., Dec. 10, 2019 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it has completed the development process and submitted a Letter to the Design History File and updated the device listing with the U.S. Food and Drug Administration (FDA) for the...

Read More »
Nextremity Solutions, Inc. Announces Success of Initial Cases Using the InCore® Lapidus Single-Use Sterile Kit
Medical Equipment

Nextremity Solutions, Inc. Announces Success of Initial Cases Using the InCore® Lapidus Single-Use Sterile Kit

New tri-planar Lapidus single-use sterile kit developed as a disposble option for health systems. WARSAW, IND. (PRWEB) NOVEMBER 22, 2019 - Nextremity Solutions, Inc., a strategic commercialization organization with a focus on the musculoskeletal space, located in “The Orthopedic Capital of the World,” Warsaw, Ind., recently completed the first several cases using its single-use sterile...

Read More »

All Topics